| Cardiology Research, ISSN 1923-2829 print, 1923-2837 online, Open Access |
| Article copyright, the authors; Journal compilation copyright, Cardiol Res and Elmer Press Inc |
| Journal website https://www.cardiologyres.org |
Original Article
Volume 8, Number 2, April 2017, pages 36-43
Arterial Velocity Pulse Index as a Novel Marker of Atherosclerosis Using Pulse Wave Analysis on High Sensitivity Troponin T in Hypertensive Patients
Figures


Tables
| Overall | hs-cTnT non-detection | hs-cTnT detection | P value | |
|---|---|---|---|---|
| Data are expressed as mean ± SD. hs-cTnT: high-sensitivity cardiac troponin T; BP: blood pressure; FBG: fasting blood glucose; IRI: immunoreactive insulin; HOMA-IR: homeostatic model assessment of insulin resistance; LDL: low-density lipoprotein; HDL: high-density lipoprotein; eGFR: estimated glomerular filtration rate; BNP: brain natriuretic peptide; hs-CRP: high-sensitivity C-reactive protein; d-ROMs: derivatives of reactive oxygen metabolites; AVI: arterial velocity pulse index; CCB: calcium channel blocker; RAS: renin-angiotensin system. | ||||
| n (male/female) | 455 (181/274) | 50 (20/30) | 405 (161/244) | 0.973 |
| Age (years) | 65 ± 11 | 61 ± 11 | 66 ± 11 | < 0.01 |
| Height (m) | 1.6 ± 0.1 | 1.6 ± 0.1 | 1.6 ± 0.1 | 0.873 |
| Body weight (kg) | 57 ± 10 | 54 ± 11 | 58 ± 11 | < 0.05 |
| Body mass index (kg/m2) | 22 ± 4 | 21 ± 3 | 23 ± 4 | < 0.05 |
| Smoking, n (%) | 109 (24) | 13 (26) | 96 (24) | 0.720 |
| Systolic BP (mm Hg) | 157 ± 8 | 157 ± 10 | 157 ± 8 | 0.953 |
| Diastolic BP (mm Hg) | 91 ± 9 | 91 ± 9 | 91 ± 10 | 0.572 |
| Pulse rate (mm Hg) | 68 ± 11 | 70 ± 11 | 68 ± 10 | 0.129 |
| Cornell voltage (mm) | 15 ± 6 | 12 ± 7 | 15 ± 5 | < 0.001 |
| Diabetes mellitus (%) | 189 (42) | 20 (40) | 169 (42) | 0.816 |
| FBG (mg/dL) | 113 ± 24 | 112 ± 20 | 113 ± 24 | 0.819 |
| IRI (μg/mL) | 7.3 ± 4.4 | 7.5 ± 4.8 | 7.3 ± 4.4 | 0.626 |
| HOMA-IR | 2.1 ± 1.4 | 2.1 ± 1.3 | 2.1 ± 1.4 | 0.864 |
| Dyslipidemia (%) | 346 (76) | 29 (54) | 317 (64) | 0.172 |
| Total cholesterol (mg/dL) | 221 ± 42 | 219 ± 42 | 221 ± 41 | 0.541 |
| LDL cholesterol (mg/dL) | 137 ± 37 | 136 ± 40 | 137 ± 38 | 0.658 |
| Triglyceride (mg/dL) | 177 ± 72 | 170 ± 83 | 179 ± 69 | 0.279 |
| HDL cholesterol (mg/dL) | 49 ± 16 | 49 ± 14 | 48 ± 16 | 0.62 |
| eGFR (mL/min/1.73 m2) | 64 ± 21 | 69 ± 21 | 63 ± 18 | < 0.05 |
| Log-urinary albumin (mg/gCr) | 1.5 ± 0.5 | 1.3±0.5 | 1.6 ± 0.5 | < 0.01 |
| Log-BNP (pg/mL) | 86 ± 67 | 57±55 | 89 ± 67 | < 0.01 |
| Log-hs-CRP (mg/L) | -1.2 ± 0.6 | -1.2±0.6 | -1.2 ± 0.6 | 0.331 |
| d-ROMs test (U. Carr) | 355 ± 93 | 330±97 | 359 ± 92 | < 0.01 |
| AVI | 28 ± 7 | 24±8 | 28 ± 7 | < 0.001 |
| Log-hs-cTnT (ng/mL) | -1.9 ± 0.2 | - | -1.9 ± 0.2 | - |
| Medication | ||||
| CCB, n (%) | 332 (73) | 36 (72) | 296 (73) | 0.652 |
| RAS inhibitor, n (%) | 223 (49) | 25 (50) | 198 (49) | 0.753 |
| Statin, n (%) | 155 (34) | 17 (34) | 138 (34) | 0.889 |
| r | ||
|---|---|---|
| Log-hs-cTnT | AVI | |
| r is correlation coefficient. *P < 0.001, **P < 0.01, ***P < 0.05. hs-cTnT: high-sensitivity cardiac troponin T; BP: blood pressure; FBG: fasting blood glucose; IRI: immunoreactive insulin; HOMA-IR: homeostatic model assessment of insulin resistance; LDL: low-density lipoprotein; HDL: high-density lipoprotein; eGFR: estimated glomerular filtration rate; BNP: brain natriuretic peptide; hs-CRP: high-sensitivity C-reactive protein; d-ROMs: derivatives of reactive oxygen metabolites; AVI: arterial velocity pulse index; CCB: calcium channel blocker; RAS: renin-angiotensin system. | ||
| Sex (female = 0, male = 1) | -0.06 | -0.13** |
| Age | 0.40* | 0.36* |
| Height | 0.06 | -0.32* |
| Body weight | 0.09 | -0.18* |
| Body mass index | 0.10*** | -0.08 |
| Smoking (no = 0, yes = 1) | 0.02 | 0.09 |
| Systolic BP | 0.08 | 0.12** |
| Diastolic BP | 0.05 | 0.08 |
| Pulse rate | 0.04 | 0.26* |
| Cornell voltage | 0.21* | 0.35* |
| Diabetes mellitus (no = 0, yes = 1) | 0.07 | 0.08 |
| FBG | 0.03 | 0.09 |
| IRI | 0.04 | 0.07 |
| Log-HOMA-IR | 0.06 | 0.06 |
| Dyslipidemia (no = 0, yes = 1) | -0.03 | -0.01 |
| Total cholesterol | -0.06 | 0.05 |
| LDL cholesterol | -0.05 | 0.04 |
| Triglyceride | -0.03 | 0.06 |
| HDL cholesterol | -0.06 | -0.04 |
| eGFR | -0.13** | -0.10*** |
| Log-urinary albumin | 0.20* | 0.29* |
| Log-BNP | 0.25* | 0.35*** |
| Log-hs-CRP | 0.10*** | 0.11*** |
| d-ROMs test | 0.35* | 0.37* |
| AVI | 0.42* | - |
| Log-hs-cTnT | - | 0.42* |
| CCB (no = 0, yes = 1) | -0.06 | -0.05 |
| RAS inhibitor (no = 0, yes = 1) | -0.06 | -0.05 |
| Statin (no = 0, yes = 1) | -0.03 | -0.02 |
| Dependent variable | β | t value | P value |
|---|---|---|---|
| (A) Subordinate factor is log-hs-cTnT. R2 = 0.23, F = 12.5, P < 0.001. (B) Subordinate factor is AVI. R2 = 0.43, F = 22.7, P < 0.001. hs-cTnT: high-sensitivity cardiac troponin T; BP: blood pressure; FBG: fasting blood glucose; IRI: immunoreactive insulin; HOMA-IR: homeostatic model assessment of insulin resistance; LDL: low-density lipoprotein; HDL: high-density lipoprotein; eGFR: estimated glomerular filtration rate; BNP: brain natriuretic peptide; hs-CRP: high-sensitivity C-reactive protein; d-ROMs: derivatives of reactive oxygen metabolites; AVI: arterial velocity pulse index; CCB: calcium channel blocker; RAS: renin-angiotensin system. | |||
| (A) AVI | 0.35 | 6.6 | < 0.001 |
| Age | 0.33 | 6.0 | < 0.001 |
| BNP | 0.14 | 3.0 | < 0.01 |
| Log-urinary albumin | 0.12 | 2.5 | < 0.01 |
| d-ROMs test | 0.11 | 2.3 | < 0.01 |
| Cornell voltage | 0.10 | 2.1 | < 0.05 |
| eGFR | -0.07 | -1.5 | 0.152 |
| Log-hs-CRP | 0.06 | 1.4 | 0.148 |
| Body mass index | 0.02 | 0.3 | 0.730 |
| (B) Log-hs-cTnT | 0.27 | 6.3 | < 0.001 |
| Age | 0.25 | 6.0 | < 0.001 |
| Cornell voltage | 0.23 | 5.6 | < 0.001 |
| Height | -0.22 | -3.6 | < 0.001 |
| Log-urinary albumin | 0.12 | 2.9 | < 0.01 |
| Pulse rate | -0.11 | -2.8 | < 0.01 |
| d-ROMs test | 0.11 | 2.7 | < 0.01 |
| BNP | 0.09 | 1.9 | 0.063 |
| Sex | 0.09 | 1.8 | 0.132 |
| Systolic BP | 0.06 | 1.5 | 0.168 |
| Log-hs-CRP | 0.06 | 1.4 | 0.173 |
| eGFR | -0.04 | -1.2 | 0.289 |
| Body weight | -0.09 | -1.9 | 0.058 |